Appendix 4C for Q2 2017

In accord with ASX requirements, Imagion Biosystems' quarterly financial statement Appendix 4C was lodged with the Australian Securities Exchange on 31 July,…


Imagion Biosystems at BIO 2017

The 2017 International Convention of BIO, the Biotechnology Innovation Organization, was held June 19-22 in San Diego. More than 16,000 individuals attended…


Tumor Detection Study Presented at "Frontiers in Biomagnetic Particles" Conference

On June 5, 2017, Imagion Biosystems Chief Scientist Erika Vreeland, PhD, presented the results of a collaborative tumor detection study to the scientific…


Imagion Biosystems Identifies Key Operational Objectives

Imagion Biosystems Limited (Imagion, ASX:IBX), is pleased to provide shareholders and interested parties an outline of its operational objectives as it moves…


Hear Bob Proulx Interviewed by Health Professional Radio

Imagion Biosystems President and CEO Bob Proulx was interviewed today by Health Professional Radio, a media network dedicated to promoting awareness on…


Imagion Biosystems Raises A$12 million in Initial Public Offering

Imagion Biosystems is now a publicly traded company after completing a heavily supported A$12 million initial public offering (IPO) on the Australian…


Senior Scientific Financial Statements 2016

View Financial Statements for Senior Scientific LLC for the period from 1 January 2016 to 17 November 2016.


Audited Accounts to 31 December 2016

View the Consolidated Financial Statements for the period 31 December 2016.


Constitution of Imagion Biosystems Limited

View the Constitution of Imagion Biosystems Limited.